Abstract
Introduction: it aimed to compare the anticoagulant effect and bleeding risk of systemic heparin anticoagulation and local sodium citrate anticoagulation in continuous renal replacement therapy(CRRT) in children with sepsis in the intensive care unit (ICU).
Method: the clinical data of 96 children with sepsis in ICU treated in Northwest Women’s and Children’s Hospitalfrom January 2021 to January 2024 were retrospectively analyzed. The children were divided into control group (CG) and observation group (OG). The coagulation function indexes, blood purification treatment effect, and the incidence of bleeding events during CRRT were compared.
Result: after treatment, activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT) were visibly increased, while fibrinogen (FIB) was visibly decreased; APTT, PT, and TT increased visibly, and FIB decreased visibly in the OG;the results of pH, HCO3-, Na+ were visibly different from those before treatment; creatinine (Cr) and urea nitrogen (BUN) were visibly lower, and the decrease of Cr and BUN in the OG was slightly higher as against the CG; the iCa2+ was visibly higher in the OG as against the CG; the incidence of bleeding in the OG was 27.08%, which was visibly lower than 35.42% in the CG (all P < 0.05).
Conclusion: local sodium citrate anticoagulation shows a good anticoagulation effect in CRRT in children with sepsis in ICU, and the bleeding risk is relatively low.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.